Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women. - Test2 - elhamkhani - TriplyDB

Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.

Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.

http://www.wikidata.org/entity/Q44620640

about

Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.Clinician's Guide to Prevention and Treatment of Osteoporosis Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.Conjugated Estrogens/Bazedoxifene (Duavee): A Novel Agent for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause And the Prevention of Postmenopausal Osteoporosis.Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture Emerging therapies for the treatment of osteoporosis Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.A practitioner's toolkit for managing the menopause.Emerging hormonal treatments for menopausal symptoms.Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause.The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.CE/BZA effects on bone and quality of life in European postmenopausal women: a pooled analysis.Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials.Tissue selective estrogen complex (TSEC): a review.Five Decades of Hormone Therapy Research: The Long, the Short, and the Inconclusive

P2860

Q26751149-7A22BC02-A618-4C92-A7E2-5044D1683D82 Q30409045-411A70D2-0C1E-4A10-9197-44371026A7A9 Q30456770-9604A40F-6966-440A-9FA1-99B3E7FCB21E Q33888331-A40ADDD1-1ADE-47EC-BB10-7BD53687CABF Q34250632-038BB080-F1AF-475B-BB1E-9333AAFD08A9 Q34315889-AC1A874F-995D-497C-BBE0-EC6CBF0659B0 Q34490225-FD79B291-E520-4011-9E86-F10352A85496 Q35170566-B96D14AC-967F-488F-9420-BC87AE430FCF Q37048294-447BEEF5-435D-4E6E-906E-AE81ACF577D8 Q37634780-DF05CA06-8D74-4E9A-A9BB-F89194C31A12 Q38149162-4A375A29-506E-410A-8492-4471D19521FD Q38192058-F7007518-9436-4C1A-BCDC-B5B44C51CA99 Q38226731-4A825CA2-FFD8-4A51-B5A9-1F1FBC6233FC Q38307019-3230D436-B0B0-4F33-8C48-7194DB34DE92 Q38793387-FF8E8AF6-4BC2-41CE-BD69-0078809069E9 Q38993271-20E447D9-8529-42FE-BF04-AABD13797306 Q39387047-294334EF-DC3D-4F6E-BA57-7F2471869173 Q39949574-B2D47A29-A603-4E37-8E97-8F67F8D159E4 Q41640781-A062458D-982A-4C3B-AD99-66DE79F68001 Q41685808-F778B90A-AAF1-4CAA-BAC4-296317ED70B7 Q53837780-A0B5EBDC-F943-43F3-848A-0E19086DACDF Q56673117-F7BA1B45-2E66-40B5-8805-8FA7EF1F5F5B

P2860

Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.

http://www.wikidata.org/entity/Q44620640

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Effects of bazedoxifene/conjug ...... bone in postmenopausal women.

@en

Effects of bazedoxifene/conjug ...... bone in postmenopausal women.

@nl

type

label

Effects of bazedoxifene/conjug ...... bone in postmenopausal women.

@en

Effects of bazedoxifene/conjug ...... bone in postmenopausal women.

@nl

prefLabel

Effects of bazedoxifene/conjug ...... bone in postmenopausal women.

@en

Effects of bazedoxifene/conjug ...... bone in postmenopausal women.

@nl

P1433

Q44620640-05B7A93E-7A47-4152-8C2D-465D26B77519

P1476

Q44620640-BAFE6F0B-1233-49BC-A12C-D99DD1274C85

P2093

Q44620640-124C5DCB-650D-499F-A36E-8858BDB91A4B

Q44620640-146DDD2B-5685-4E1A-986A-4ED6E374BE22

Q44620640-1795DE17-CE71-4F3A-A1DF-A1901AE81BBD

Q44620640-E322FAAF-2E09-495E-8065-A81362A1685F

P2860

Q44620640-0258911B-B0A2-4C67-8ADA-AC857E44C02A

Q44620640-05B6160B-B880-461B-BEE8-9131EA8825B3

Q44620640-065C3BE8-5CCE-4FE0-B809-5CCF367FF41F

Q44620640-154F5761-28F2-47E7-8B9A-989AC41A24BD

Q44620640-2C0FF3D4-F3FD-4AC6-8F3B-0267A3C7E363

Q44620640-2EB5EA4D-CBD4-4152-962B-1813C6363CCD

Q44620640-3A88B2A2-2F28-4919-9017-10D8B4E1538D

Q44620640-483F344B-8664-4D34-B9E6-DAF113F2162F

Q44620640-4EBF9257-D399-4419-BC74-C514F5BA959C

Q44620640-82856331-8AEC-4EB0-A610-8B7D3E70ED1C

P304

Q44620640-3D15A947-FD5C-4D04-81D7-DF03786260FF

P31

Q44620640-FC8A0D9A-F23C-4636-BB1F-138CBBAB744A

P356

Q44620640-5D9E8811-6410-48B0-8463-03684ED86839

P433

Q44620640-CCB4B8AC-4B15-41EE-812D-BD9A76008BD3

P478

Q44620640-FA96A22E-96C4-4752-A054-6AA929EED41A

P577

Q44620640-37E17C86-4106-4D73-A1AE-AC186077C91F

P698

Q44620640-E5139808-45C8-4EB4-97F3-249F8A6EF833

P356

13697137.2012.717994

P1433

P1476

Effects of bazedoxifene/conjug ...... bone in postmenopausal women.

@en

P2093

A A Chines

http://www.w3.org/2001/XMLSchema#string

B S Komm

http://www.w3.org/2001/XMLSchema#string

K Pan

http://www.w3.org/2001/XMLSchema#string

S Mirkin

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Increased risk of endometrial carcinoma among users of conjugated estrogens

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.

Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.

The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.

Hormone use and patient concerns after the findings of the Women's Health Initiative.

Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.

P304

338-346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13697137.2012.717994

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23038989

http://www.w3.org/2001/XMLSchema#string